• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of September 26, 2012

  • Print
  • Share
  • E-mail

Product Detail

Product Description Pramipexole Dihydrochloride Tablets, 0.125 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5248-92
Recall Number D-1678-2012
Classification Class III
Code Info Lot numbers: KW10J511, KW10J512, KW10J513, KW10J514, KW10J515, BJ3167, BJ3172, BJ3177, BJ3179, BJ3188, BJ3182. Exp. 09/12
Product Distributed Qty 41,761bottles.
Reason For Recall Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.

Event Detail

Event Id 63160
Product Type Drugs
Status Ongoing
Recalling Firm Sandoz Incorporated
City Broomfield
State CO
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-09-12
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide